{"symbol":"PFE","fiscalQuarter":"Q3-2020","reportDate":"2020-10-27","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2020","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 1.29%","keyNumbers":[{"metric":"EPS","actual":"$0.72","expected":"N/A","surprise":"+3.15%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on advancing our pipeline and addressing market needs."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized ongoing efforts to meet market demands."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock declined by 1.29% on the day, likely due to the lack of revenue data and forward guidance, which may have left investors uncertain about future performance.","metaDescription":"Pfizer Inc (PFE) Q3 2020 earnings: EPS beat by 3.15%, revenue not disclosed. Stock down 1.29%. Full breakdown."}}